MV 140Alternative Names: MV140
Latest Information Update: 17 Aug 2015
At a glance
- Originator Immunotek SL
- Class Bacteria; Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Urinary tract infections
Most Recent Events
- 17 Jul 2015 Phase-III clinical trials in Urinary tract infections (Prevention, Recurrent) in Spain (Sublingual)